Background: On 3rd February 2020, the US National Institute of Allergy and Infectious Diseases (NIAID) announced that HVTN 702, a large-scale HIV vaccine efficacy trial of a vaccine candidate, has stopped vaccinations because the vaccine does not prevent HIV. The trial, conducted at 14 sites across South Africa, followed more than 5400 HIV-negative 18–35-year-olds over […]